FAIM-L Is an IAP-Binding Protein That Inhibits XIAP Ubiquitinylation and Protects from Fas-Induced Apoptosis
- Rana S. Moubarak1,2,3,
- Laura Planells-Ferrer1,2,3,
- Jorge Urresti1,2,3,
- Stéphanie Reix1,2,3,
- Miguel F. Segura1,
- Paulina Carriba1,2,3,
- Fernando Marqués-Fernàndez1,2,3,
- Carme Sole4,
- Nuria Llecha-Cano5,
- Joaquin Lopez-Soriano1,2,3,
- Daniel Sanchis6,
- Victor J. Yuste2, and
- Joan X. Comella1,2,3
- 1Institut de Recerca de l'Hospital Universitari de la Vall d'Hebron (VHIR), 08035 Barcelona, Spain,
- 2Institut de Neurociències, Departament de Bioquímica i Biologia Molecular, Facultat de Medicina, Universitat Autònoma de Barcelona, 08193 Bellaterra Spain,
- 3Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Spain,
- 4Departament de Ciències Experimentals i de la Salut, Cell Signalling Unit, Universitat Pompeu Fabra, 08003 Barcelona, Spain,
- 5Laboratoris Clinics, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain, and
- 6Institut de Recerca Biomèdica de Lleida, Universitat de Lleida, 25198 Lleida, Spain
-
Author contributions: R.S.M., M.F.S., C.S., and J.X.C. designed research; R.S.M., L.P.-F., J.U., P.C., F.M.-F., C.S., and D.S. performed research; R.S.M., L.P.-F., S.R., and J.L.-S. contributed unpublished reagents/analytic tools; R.S.M., L.P.-F., M.F.S., N.L.-C., V.J.Y., and J.X.C. analyzed data; R.S.M. and J.X.C. wrote the paper.
Abstract
The neuronal long isoform of Fas Apoptotic Inhibitory Molecule (FAIM-L) protects from death receptor (DR)-induced apoptosis, yet its mechanism of protection remains unknown. Here, we show that FAIM-L protects rat neuronal Type II cells from Fas-induced apoptosis. XIAP has previously emerged as a molecular discriminator that is upregulated in Type II and downregulated in Type I apoptotic signaling. We demonstrate that FAIM-L requires sustained endogenous levels of XIAP to protect Type II cells as well as murine cortical neurons from Fas-induced apoptosis. FAIM-L interacts with the BIR2 domain of XIAP through an IAP-binding motif, the mutation of which impairs the antiapoptotic function of FAIM-L. Finally, we report that FAIM-L inhibits XIAP auto-ubiquitinylation and maintains its stability, thus conferring protection from apoptosis. Our results bring new understanding of the regulation of endogenous XIAP by a DR antagonist, pointing out at FAIM-L as a promising therapeutic tool for protection from apoptosis in pathological situations where XIAP levels are decreased.
- Received June 12, 2013.
- Revision received October 11, 2013.
- Accepted October 31, 2013.
- Copyright © 2013 the authors 0270-6474/13/3319262-14$15.00/0





